进一步推进弥漫性肝病的MRI精准诊断与定量研究  

To Further Promote Accurate Diagnosis and Quantitative Research of Diffuse Liver Disease Based on MRI

作　　者：杨正汉[1] 杨大为[1] YANG Zhenghan;YANG Dawei(Department of Radiology,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China)

机构地区：[1]首都医科大学附属北京友谊医院放射科,北京100050

出　　处：《中国医学影像学杂志》2022年第2期97-99,共3页Chinese Journal of Medical Imaging

基　　金：国家自然科学基金项目(61871276,62171298,82071876);首都医学发展科研基金项目(2018-2-2023);国家重点研发计划项目(2016YFC0106900);北京市自然科学基金项目(7184199)。

摘　　要：弥漫性肝病是我国面临的重大健康问题。弥漫性肝病随疾病进展会表现为炎症、脂肪变性、肝纤维化及肝硬化等不同病理改变。准确评估弥漫性肝病的病理改变及程度对于治疗决策、预后评估、药物疗效评价等有重要意义。近年,多种定量MRI技术在弥漫性肝病的诊断与评估中展现出较好的应用前景,有待进一步深入研究。Diffuse liver disease is a major health problem in China.Diffuse liver disease may show different pathological changes such as inflammation,steatosis,fibrosis and cirrhosis.Accurate evaluation of pathological changes and degree of diffuse liver disease is of great clinical significance for treatment decision,prognosis evaluation and drug efficacy evaluation.In recent years,a variety of quantitative MRI techniques have shown good application prospects in the diagnosis and evaluation of diffuse liver disease,which needs further research.

关 键 词：弥漫性肝病 磁共振成像 诊断 鉴别 综述 

分 类 号：R445.2[医药卫生—影像医学与核医学] R575[医药卫生—诊断学]